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ABSTRACT
The purpose of the study was to investigate the effects of H1-antihistamines of the 1st generation (antazoline, bromadryl, bromphe-
niramine, dithiaden, cyclizine, chlorcyclizine, chlorpheniramine, clemastine) and the 2nd generation (acrivastine, ketotifen, and lorata-
dine) on the respiratory burst of phagocytes. Reactive oxygen species generation in neutrophils isolated from rat blood was measured 
using luminol-enhanced chemiluminescence. Changes in nitrite formation and iNOS protein expression by RAW 264.7 macrophages 
were analysed using Griess reaction and Western blotting. The antioxidative properties of drugs in cell-free systems were detected 
spectrophotometrically, luminometrically, fluorimetrically, and amperometrically. The majority of the H1-antihistamines tested (bro-
madryl, brompheniramine, chlorcyclizine, chlorpheniramine, clemastine, dithiaden, and ketotifen) exhibited a significant inhibitory 
effect on the chemiluminescence activity of phagocytes. H1-antihistamines did not show significant scavenging properties against 
superoxide anion and hydroxyl radical, thus this could not contribute to the inhibition of chemiluminescence. H1-antihistamines had a 
different ability to modulate nitric oxide production by LPS-stimulated macrophages. Bromadryl, clemastine, and dithiaden were the 
most effective since they inhibited iNOS expression, which was followed by a significant reduction in nitrite levels. H1-antihistamines 
had no scavenging activity against nitric oxide. It can be concluded that the effects observed in the H1-antihistamines tested are not 
mediated exclusively via H1-receptor pathway or by direct antioxidative properties. Based on our results, antihistamines not interfering 
with the microbicidal mechanisms of leukocytes (antazoline, acrivastine and cyclizine) could be used preferentially in infections. Other 
antihistamines should be used, under pathological conditions accompanied by the overproduction of reactive oxygen species. 
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lipophilic molecules – allow them to associate with the 
cell membrane. Moreover, they are able to inhibit the 
activity of calcium-dependent enzymes and affect cal-
cium mobilization and discharge of intracellular calcium 
stores, responsible for various inflammatory reactions 
including histamine secretion, synthesis of eicosanoids or 
reactive oxygen species (ROS) generation by phagocytes. 
NADPH oxidase, located in the plasma membrane and in 
the membrane of specific granules, produces superoxide 
anion from which other ROS derive, such as hydrogen 
peroxide, hypochlorite, and hydroxyl radicals. One quick 
and sensitive method of measuring the generation of these 
metabolites is chemiluminescence (CL), as described by 
Pavelková & Kubala (2004). 
Besides ROS, the production of reactive nitrogen spe-
cies belongs to the important microbicidal tools of profes-
sional phagocytes, mainly macrophages, during the fight 
against pathogenic microorganisms. Nitric oxide (NO), 
which belongs to the group of reactive nitrogen species, is 
Introduction
The biological effects of histamine are mediated via 
four types of histamine receptors (H1–H4) expressed on 
various cell types (Tiligada et al., 2009). The binding 
of histamine to the H1 receptor induces progress of the 
allergic symptom, which is particularly prevented using 
histamine H1-receptor blockers. These drugs, known as 
H1-antihistamines, are clinically used as anti-allergic 
or anti-emetic drugs (De Vos, 1999; Drábiková et al., 
2002). Results published by several authors (e.g. Church, 
2001) have suggested that the chemical structure of 
some H1-antihistamines – namely positively charged 
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one of the basic biological mediators which play essential 
bioregulatory roles in a wide range of processes critical 
to normal functions in the cardiovascular, nervous, and 
immune systems. In the presence of inducible nitric oxide 
synthase (iNOS) in response to inflammatory stimuli, e.g. 
Gram-negative bacterial lipopolysaccharide (Moncada 
& Higgs, 1993), NO is generated by phagocytes in an 
L-arginine pathway. Detection of iNOS protein expres-
sion and nitrite concentrations are reliable methods for 
verifying the influence of drugs on NO production by 
cells (Pekarová et al., 2009). 
Incomplete information exists about the effects of 
H1-antihistamines on the production of ROS and NO by 
phagocytes. Therefore, the purpose of the present work 
was to investigate the changes in ROS generation, nitrite 
formation, and iNOS protein expression by phagocytes. 
To describe the direct interactions of H1-antihistamines 
with ROS and NO, the scavenging properties of these 
drugs against ROS and NO in cell-free systems were also 
determined. 
Materials and Methods
Antihistamines of the 1st generation – antazoline (ANT), 
bromadryl (BRO), brompheniramine (BPH), dithiaden 
(DIT), cyclizine (CYC), chlorcyclizine (CHC), chlorphe-
niramine (CPH), clemastine (CLE), and the 2nd genera-
tion – acrivastine (ACR), ketotifen (KET) and loratadine 
(LOR) – were purchased from European producers. The 
stock solutions of drugs (3×10–3 M) dissolved in distilled 
water were stored at –20 °C. For the experiments, stock 
solutions were diluted in Dulbecco’s Modified Eagle’s 
Medium (DMEM) supplemented with heat-inactivated 
10% fetal bovine serum, and the final concentration of 
5×10–5 M was tested. Lipopolysaccharide (LPS) from 
Escherichia coli serotype 0111:B4 (Sigma-Aldrich, USA) 
was dissolved in phosphate buffer solution (1 mg/ml) and 
stored at –20 °C. Other chemicals were purchased from 
local distributors. 
Cells
Neutrophils isolated from peripheral blood of Wistar rats 
were used for the analyses of antihistamine effects on 
the production of reactive oxygen species. Conventional 
three-month-old male rats were kept under standard 
conditions in plastic cages, receiving a commercial stan-
dard diet with water given ad libitum. The experimental 
protocols were reviewed and approved by the Ethical 
Committee of the Institute of Biophysics AS CR, in 
accordance with European Community guidelines. The 
rats were anesthetized by intraperitoneal administration 
of ketamine/xylazine (20/2 mg per 100 g of body weight). 
Five ml of heparinized blood (50 IU/mL) was collected 
from the right ventricle, and the animals were sacrificed. 
Erythrocytes were removed after 1h sedimentation and 
leukocytes with plasma were washed twice in phosphate 
buffer solution (250  ×  g, 7 min) and resuspended in 
HBSS to a final concentration of 1×106 PMNL/sample. 
The respiratory burst of isolated leukocytes was mea-
sured according to Pavelková & Kubala (2004), using a 
microplate luminometer LM-01T (Immunotech, Czech 
Republic).
Murine leukemic macrophage-like RAW 264.7 cells 
(ATCC, USA) were used for analyses of H1-antihistamine 
effects on the production of reactive nitrogen species. 
Cells were grown in DMEM supplemented with 10% fetal 
bovine serum, gentamycin, glucose, and NaHCO3 in a 
CO2 incubator (5% CO2 and 95% air humidity) at 37 °C. 
Cells were seeded at an initial density of 2.5×106 cells/ml/
well in 6-well tissue culture plates and preincubated with 
H1-antihistamine for 60 min. Cells were subsequently 
stimulated with LPS in the concentration 0.1 μg/ml and 
incubated for further 24  h. Non-stimulated cells incu-
bated in the absence of H1-antihistamines served as nega-
tive control. Cells stimulated with LPS and incubated in 
the absence of H1-antihistamines were used as positive 
control. After 24 h, supernatants were harvested and the 
nitrite accumulation was determined. The cells were 
lysed and used for the measurement of ATP content and 
iNOS protein expression.
Chemiluminescence (CL) determination of 
reactive oxygen and nitrogen production
Briefly, the reaction mixture consisted of 1×106 cells/well 
in HBSS, 1 mM luminol (stock solution of 10 mM luminol 
in 0.2 M borate buffer), one of the antihistamines, and 
62.5 μg/mL opsonized zymosan particles (OZP). The total 
reaction volume of 250 μL was adjusted with HBSS. The 
CL emission was followed up for 1h at 37  °C. The area 
under the obtained curve expressed as relative light units 
(RLU)/60min was recorded, and the data were expressed 
as percentage of the positive control. 
Activity of myeloperoxidase
The effect of the antihistamines on the activity of myelo-
peroxidase (MPO) isolated from lysed HL-60 cells was 
analysed by bromide-dependent chemiluminescence (Číž 
et al., 2007). 
Evaluation of antioxidant capacity
The antioxidant capacity of H1-antihistamines was 
assessed spectrophotometrically (superoxide anion gen-
erated by xanthine/xanthine oxidase), luminometrically 
(hydroxyl radical generated by Fenton chemistry), and 
fluorimetrically (peroxyl radical generated by thermal 
decomposition of 2,2-azobis (2-amidinopropane) hydro-
chloride according to Nosál’ et al., 2005 and Číž et al., 
2010. 
Testing cell viability 
The viability of RAW 264.7 cells was tested by the com-
mercial ATP cellular kit (BioThema, Sweden). Cells were 
incubated according to the experimental procedure, 
supernatants were removed, and cells were lysed by 
the Somatic cell ATP releasing reagent (Sigma Aldrich, 
USA). Then 50 μl of lysate was mixed with 20 μl of ATP 
reagent containing D-luciferin, luciferase, and stabilizers. 17
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Intracellular ATP contents were determined luminomet-
rically using a luminometer Orion II (Berthold Detection 
Systems GmbH, Germany). 
Determination of nitrite production by cells
Detection of nitrites (NO2
–) accumulated in the cell 
supernatants was performed using Griess reagent. The 
volume of 150  μl of the cell supernatant was incubated 
with 150  μl Griess reagent (Sigma-Aldrich, USA) for 
15 min in the dark, at room temperature, and the absor-
bance was measured at 546 nm using a Spectra Rainbow 
UV /Vis microplate reader (SLT T ecan, Germany). The 
concentrations of nitrites were derived from regression 
analysis using serial dilutions of sodium nitrite as a 
standard. The concentration values of each sample are 
expressed as percentage of the positive control. 
Determination of iNOS protein expression in cells
Cells were lysed with 1% SDS lysing buffer with the addi-
tion of 1% phenylmethanesulphonylfluoride. The protein 
volume in the cell samples was determined using com-
mercial BCA protein assay (Pierce, USA). The same con-
centration of proteins (22 μg) was separated by 7.5% SDS-
PAGE and then transferred to a polyvinylidene difluoride 
membrane (Millipore, USA) in a buffer containing Tris-
glycine and 20% methanol. Membranes were incubated 
with 5% fat-free milk in Tris buffer-Tween 20 (TBS-T) at 
room temperature for 1 h. The protein was labeled using 
a mouse antibody (1:1 000) specific to iNOS (Anti-iNOS/
NOS Type II mAb, BD Transduction Laboratories, USA) 
and a horseradish peroxidase-conjugated goat anti-mouse 
IgG antibody (1:2 000; ECL™ Anti-mouse IgG, Amersham, 
Biosciences, USA). The membranes were washed three 
times in TBS-T buffer for 10 min. Subsequently, immu-
noreactive bands were visualized using ECL detection 
reagent (Detection reagents kit, Pierce, USA) and exposed 
to radiographic film (AGFA, Belgium). Relative levels of 
proteins were quantified by scanning densitometry using 
the ImageJ™ program, and the optical density for each 
individual band was expressed as percentage of the posi-
tive control. 
Amperometrical detection of NO scavenging
The scavenging properties of H1-antihistamines against 
N O  w e r e  e v a l u a t e d  i n  a  c h e m i c a l  s y s t e m  a m p e r o -
metrically, using three electrode systems. A porphyrinic 
microsensor working electrode, platinum wire counter 
electrode, and a miniature saturated silver/silver chlo-
ride reference electrode were connected to the ISO-NO 
MARK II potentiostat (WPI, USA). The measurement 
was performed using distilled water saturated with pure 
NO gas (according to the WPI manual and Pekarová et 
al., 2009). The injection of 1 μl of the NO-saturated water 
into the glass vial (final concentration of NO in the vial 
= 595 nM) caused a rapid increase (peak time = 15 ± 5 s) 
with a subsequent gradual decrease of NO-induced signal 
until it reached the background current. The potential 
NO scavenger causes a rapid decrease of the NO-induced 
signal. 
The signal was measured for 280  s to obtain kinetic 
curves. Then the integral areas under the control curve 
and sample curves were calculated, and the scavenging 
activity of the drugs was evaluated.
Statistical evaluation
Data are expressed as the mean ± standard error of the 
mean (SEM) of at least three independent experiments 
that were run in duplicates. Results were analyzed by 
Student’s two-tailed t-test using Statistica software 
(StatSoft, USA), and values below 0.05 (*) were considered 
statistically significant.
Results
H1-antihistamines were evaluated for their effects on cell 
viability. None of the compounds tested in the concentra-
tion used affected cell viability after 24 h coincubation. 
According to their ability to affect the chemilu-
minescence response of rat neutrophils isolated from 
whole blood, H1-antihistamines could be divided into 
three groups (Figure 1). The majority of compounds 
(bromadryl, brompheniramine, chlorcyclizine, chlor-
pheniramine, clemastine, dithiaden, and ketotifen) 
exerted strong, statistically significant inhibition of 
the chemiluminescence response. On the other hand, 
loratadine was the only H1-antihistamine studied which 
significantly enhanced the chemiluminescence response 
of neutrophils. Acrivastine, antazoline, and cyclizine did 
not exert any effects on the chemiluminescence response 
of neutrophils.
Since the suppression of neutrophil chemilumines-
cence could be due to direct scavenging of reactive oxygen 
metabolites by H1-antihistamines, scavenging properties 
of H1-antihistamines against superoxide anion, hydroxyl, 
Figure 1. Eff  ects of H1-antihistamines in the concentration of 
5×10–5 M on reactive oxygen species formation in neutrophils 
isolated from rat blood, measured as their chemiluminescence 
activity. Data are expressed as mean ± SEM of at least three inde-
pendent experiments, which were run in duplicates. The symbol 
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and peroxyl radicals were evaluated in a subsequent 
experiment. None of the H1-antihistamines tested influ-
enced myeloperoxidase activity (data not shown). It was 
found that only bromadryl and dithiaden significantly 
scavenged peroxyl radicals. Acrivastine and cyclizine 
scavenged peroxyl radicals insignificantly, and all other 
H1-antihistamines studied had no effect on peroxyl radi-
cals. None of the compounds tested exerted significant 
effects on superoxide anion or hydroxyl radical generation 
(data not shown). 
Table 1 summarizes the effects of H1-antihistamines 
on NO production by murine RAW264.7 macrophage-like 
cells. Bromadryl, chlorcyclizine, clemastine, dithiaden, 
and loratadine significantly suppressed nitrite accu-
mulation, an indirect marker of NO production, in cell 
supernatants. Some of these compounds (bromadryl, 
clemastine, dithiaden) and some other H1-antihistamines 
(brompheniramine, ketotifen) significantly inhibited 
iNOS expression in cells. None of the H1-antihistamines 
tested proved to directly scavenge NO (data not shown).
Discussion
H1-antihistamines play a very important role in the 
regulation of the metabolic activity of phagocytes. We 
studied H1-antihistamine effects on the production 
of ROS and NO in isolated rat neutrophils and murine 
macrophage RAW 264.7 cell line, which is a convenient 
cell model for monitoring NO production after stimula-
tion with LPS (Yang et al., 2009). Cell-free systems were 
used for the analyses of the antioxidative properties of 
H1-antihistamines (Nosál’ et al., 2005).
The majority of the H1-antihistamines tested (bro-
madryl, brompheniramine, chlorcyclizine, chlorpheni-
ramine, clemastine, dithiaden, and ketotifen) exhibited 
a significant inhibitory effect on the respiratory burst 
o f  p ha g ocyt es.  CL  o f  p ha g ocyt es  is  c o ns i d e r ed  t o  be  
dependent on the myeloperoxidase system. However, 
the MPO activity was not significantly suppressed by 
H1-antihistamines in the concentration tested, thus 
this effect may be excluded. Direct scavenging of ROS 
by H1-antihistamines could be another possible reason 
for the decreased CL signal. However, the generation of 
peroxyl radicals by thermal decomposition of 2,2-azobis 
(2-amidinopropane) hydrochloride was significantly 
inhibited only with bromadryl and dithiaden. These 
H1-antihistamines could play a role in the prevention of 
injury induced by lipid peroxidation. The other antihis-
tamines had no effect in this system. None of the anti-
histamines showed direct scavenging properties against 
superoxide anion and hydroxyl radical; thus this could not 
contribute to the inhibition of CL. Other possible mecha-
nisms for this inhibitory effect by antihistamines, such 
as interference with calcium ion movement, enzymatic 
pathways, or second messengers, should be studied (Leurs 
et al., 1995; Church, 2001).
The H1-antihistamines tested had different abilities 
to  m od ula te  N O  p r od u cti o n  b y  LP S- stim ula ted  ma c -
rophages. Some of the drugs – including bromadryl, 
clemastine, and dithiaden – inhibited iNOS expression 
in LPS-stimulated cells. This inhibition was followed by 
a significant reduction in nitrite levels. In the presence 
of brompheniramine and ketotifen, the LPS-induced 
iNOS protein expression was also inhibited; however, the 
decrease in nitrite accumulation was less pronounced. 
On the other hand, chlorcyclizine and loratadine did 
not affect iNOS protein expression, but they were able 
to decrease nitrite levels in the cell supernatants. Finally, 
acrivastine, antazoline, chlorpheniramine, and cyclizine 
had no effect on nitrite accumulation and iNOS protein 
expression. 
The drugs studied had no scavenging activity against 
N O  i n  t h e  c h e m i c a l  s y s t e m .  T h e r e f o r e ,  w e  s u p p o s e  
that the inhibitory effect on macrophage iNOS protein 
expression could be explained by the ability to affect the 
intracellular signaling pathways that lead to NO produc-
tion. It was previously documented that the activation 
of histamine receptors leads to the activation of nuclear 
factor-κB, which is responsible for the regulation of iNOS 
expression (Bakker et al., 2001). Moreover, the effect of 
H1-antihistamines may be mediated via affection of iNOS 
enzyme activity in cases where the decrease in nitrite 
accumulation was not accompanied by inhibition of iNOS 
protein expression. 
Our previous results (Králová et al., 2009) showed 
that the structural properties of H1-antihistamines, par-
ticularly lipophilicity, significantly affected the biological 
activity of macrophages. On the other hand, the effects of 
the H1-antihistamines tested did not appear to be limited 
by their hydrophobicity, thus pointing to the involvement 
of the membrane as their site of action. 
It can be concluded that the observed effects of 
the drugs tested are not mediated exclusively via the 
H1-receptor pathway or by direct antioxidative properties. 
Table 1. Effects of H1-antihistamines in the concentration of 5x10-5 
M on nitrite concentrations in cell supernatants and iNOS protein 
expression in RAW 264.7 cells stimulated by 0.1 μg/ml LPS. 
H1-antihistamine
NO2
- concentration iNOS expression
[% of control]
BPH 89.0 ± 4.9  61.0 ± 6.4 *
CHC 51.5 ± 0.3 * 86.2 ± 3.0
CLE 56.9 ± 4.6 * 40.7 ± 3.7 *
CPH 87.3 ± 1.2 81.0 ± 3.7
DIT 56.1 ± 3.3 * 50.9 ± 4.0 *
BRO 72.7 ± 6.3 * 49.5 ± 4.2 *
KET 95.9 ± 0.5 76.5 ± 2.3 *
ANT 97.2 ± 1.0 84.3 ± 2.6
CYC 88.8 ± 0.8 84.4 ± 4.4
ACR 89.6 ± 0.6 98.4 ± 2.1
LOR 54.0 ± 1.7 * 84.8 ± 6.4
Data are expressed as mean ± SEM of at least three independent experi-
ments, which were run in duplicates. The symbol (*) shows significant differ-
ences (p<0.05), as compared to control cells.19
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Based on our results, antihistamines not interfering with 
the microbicidal mechanisms of leukocytes (antazoline, 
acrivastine, and cyclizine) could be used preferentially 
in infections. Conversely, antihistamines inhibiting the 
production of ROS and NO should be used preferentially 
under pathological conditions accompanied by overpro-
duction of ROS.
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